Salute e Benessere

Variants in the genome interact with each other and with the environment to…

It is well established that the "bad" cholesterol (also called non-HDL cholesterol and LDL cholesterol) directly contributes to the development of cardiovascular disease. It is well established that the "bad" cholesterol (also called non-HDL cholesterol and LDL cholesterol) directly contributes to the development of cardiovascular disease. The environment and the genome both influence bad cholesterol and consequently cardiovascular health. This influence can be complex and…
PR Newswire
14/09/2023

Viral Vector Manufacturing Market to Grow Substantially by 2029- Brandessence…

The business intelligence report curated by Brandessence Market Research aims at empowering industry participants with an extensive overview of this marketplace. It offers detailed insights into the key growth drivers, restraints, opportunities, and challenges, that are shaping the profit trajectory of this industry vertical. A scrutiny of the listed segments and geographical landscape is entailed in this report. It further contains a country-wise breakdown of each region with detailed insights…
PR Newswire
14/09/2023

Blood Group Typing Market worth $3.0 billion | MarketsandMarkets

Blood Group Typing Market in terms of revenue was estimated to be worth $2.0 billion in 2023 and is poised to reach $3.0 billion by 2028, growing at a CAGR of 8.7% from 2023 to 2028 according to a new report by MarketsandMarkets™. The need for blood donations is on the rise due to the growing incidence of chronic diseases and an increasing number of surgical procedures, which, in turn, highlights the essential role of precise blood group typing in facilitating secure and efficient blood…
PR Newswire
14/09/2023

Healthcare Cognitive Computing Market Size is Expected to Reach USD 108.45…

This business intelligence report offers a deep dive assessment of the primary growth drivers, challenges, opportunities, and restraints. The report predominantly aims at empowering businesses with extensive knowledge about this industry vertical. A 360-degree outlook of the top segments and geographies are entailed in this study. It also sheds light into the competitive terrain of this market within depth information about each operating player. This business intelligence report offers a…
PR Newswire
14/09/2023

Sperm Bank Market to Grow Substantially over 2022-2029 | Brandessence Market…

The business intelligence report on this market offers a deep dive assessment of the top factors influencing the expansion trajectory of this industry. Growth drivers, restraints, challenges, and opportunities pertaining to this industry are well elaborated in this marketspace. It also offers a 360-degree outlook of the top market segments and geographical landscape with accurate growth projections of each region, country, and niche segments. Apart from that, it highlights each player operating…
PR Newswire
14/09/2023

Navigating the Diabetes Disease Landscape: Market Insight Epidemiology…

Symptoms of Diabetes Symptoms of Diabetes Increased Thirst and Urination : Frequent thirst and urination are common early symptoms of diabetes. Excessive glucose in the bloodstream leads to increased urine production, resulting in dehydration and an unquenchable thirst. Unexplained Weight Loss : Sudden and unexplained weight loss is often seen in individuals with uncontrolled diabetes, particularly in cases of type 1 diabetes. The body's inability to utilize glucose for energy leads...
PR Newswire
14/09/2023

The Cell and Gene Therapy CROs Market is anticipated to grow at an annualized…

Due to the upsurge in the research and development related to genetic engineering, there has been a considerable increase in the development of cell and gene therapies. Consequently, there has been a parallel rise in outsourcing of services as more clinical studies are anticipated to start. Specifically, cell and gene therapy companies have made significant investments to support the development / adoption of advanced tools, technologies and platforms, to generate more robust and evidence based…
PR Newswire
14/09/2023

Digestive Enzyme Market to Grow Significantly by 2029- Brandessence Market…

This business intelligence report offers a scrutiny of the top factors reshaping the trends and dynamics of this market space. It has been curated with an aim to help businesses make informed decisions by providing them with credible data related to numerous aspects of this market. Alongside, the major segments and regions are evaluated accurately with an aim to determine the size and scope of the overall market. The report also contains accurate revenue projections, estimated CAGR, past…
PR Newswire
14/09/2023

Exploring Parkinson's Disease Statistics: Market Insight, Epidemiology ,Forecast…

Advancements in Parkinson's Disease Diagnosis: Facilitating Patient Care Advancements in Parkinson's Disease Diagnosis: Facilitating Patient Care Parkinson's Disease can be challenging to diagnose, often leading to delayed treatment initiation. However, recent advancements in diagnostic tools have empowered healthcare professionals to identify the disease more accurately and at earlier stages. These advancements include: Biomarker Research Biomarkers are measurable substances or...
PR Newswire
14/09/2023

Trading in GN Store Nord shares by board members, executives and associated…

GN Store Nord has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord made by persons discharging managerial responsibilities in GN Store Nord and/or persons closely associated with them. Details of the person discharging managerial responsibilities/person closely associatedNameRonica WangReason for the notificationPosition/statusMember Of the BoardInitial...
Nasdaq GlobeNewswire
14/09/2023

ERS Genomics & Demeetra Enter Into CRISPR/Cas9 Licensing Agreement

ERS founder, Dr. Emmanuelle Charpentier, won the 2020 Nobel Prize for the discovery of CRISPR/Cas9. The ERS patent portfolio is the definitive collection of proprietary rights to this gene editing technology. ERS founder, Dr.Emmanuelle Charpentier, won the 2020 Nobel Prize for the discovery of CRISPR/Cas9. The ERS patent portfolio is thedefinitivecollection of proprietary rights to this gene editing technology. Demeetra, headquartered inKentucky, is a biotechnology company whose...
PR Newswire
14/09/2023

OKYO Pharma Announces Pricing of $4.0 Million Registered Direct Offering of…

LONDON and NEW YORK, Sept.14, 2023(GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO) (“OKYO” or the “Company”), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease (“DED”), today announced the pricing of a Company best efforts registered direct offering of 2,666,667 ordinary shares at an offering price of $1.50 per ordinary share conducted without an underwriter or placement agent to individuals and institution. The gross proceeds to...
Nasdaq GlobeNewswire
14/09/2023

OKYO Pharma Limited Announces Withdrawal of Public Offering

LONDON and NEW YORK, Sept.14, 2023(GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO) (“OKYO” or the “Company”), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease (DED) to address the significant unmet need in this multi-billion-dollar market, today announced the withdrawal of its proposed public offering of ordinary shares and its termination of Freedom Capital Markets as underwriter. The decision was made in response to changing...
Nasdaq GlobeNewswire
14/09/2023

GN completes divestment of BelAudição

Continued execution of GN's capital plan generating net proceeds of DKK ~500m Today, GN has successfully completed the divestment of BelAudição, Unipessoal Lda (“BelAudição”) to MCH Private Equity, bringing in net proceeds of DKK ~500 million. Following the announcement on June 28, 2023, the buyer has obtained anti-trust clearance and completed financing.The transaction demonstrates GN's commitment to its successful strategy of not owning retail and instead focus on being a key supplier...
Nasdaq GlobeNewswire
14/09/2023

FibroBiologics to Provide Company Update at Upcoming Conferences

LSI Europe '23 Emerging MedTech Summit (Barcelona, September 18-22) LSI Europe '23 Emerging MedTech Summit ( Barcelona,September 18-22 ) Cell & Gene Meeting on the Mesa ( Carlsbad, California.October 10-12 ) "Our presence at these conferences illustrates our commitment to staying at the forefront of developing innovative approaches to treatment of chronic diseases, sharing insights, and fostering collaborations with academia and the biotech community that will drive progress...
PR Newswire
14/09/2023

SHEIN Allocates Additional US$85 Million for Global Community Empowerment

SHEIN's ESG roadmap, evoluSHEIN, is the company's strategy to address social and environmental challenges and make a positive impact on society. The roadmap comprises nine priorities organized under three strategic pillars – People, Planet and Process. SHEIN's ESG roadmap, evoluSHEIN, is the company's strategy to address social and environmental challenges and make a positive impact on society. The roadmap comprises nine priorities organized under three strategic pillars – People, Planet and...
PR Newswire
14/09/2023

Dr. Jonathan Milner opposes Danaher's acquisition of Abcam and calls for EGM to…

Dr. Jonathan Milner opposes Danaher's acquisition of Abcam and calls for EGM to replace BoardCAMBRIDGE, England, 14 September 2023– Dr. Jonathan Milner, the founder and one of the largest investors in Abcam plc (“Abcam” or the “Company”) (NYSE: ABCM) with ownership of 6.14%, today announces his decision to vote against the proposed acquisition of Abcam by Danaher Corporation (NYSE: DHR) or its affiliates (“Danaher”). In addition to this, he will formally request...
Nasdaq GlobeNewswire
14/09/2023

Paingone Plus Tens Pen: An effective pain-relief solution

There are several advantages that a person suffering from pain can make use of if they purchase Paingone Plus Tens Pen. Apart from the fact that one can effectively reduce pain in various parts to a great extent, its compact design has made it easy for people to carry it. It has a pen-like structure wherein the stimulation is generated from the device's tip. There are several advantages that a person suffering from pain can make use of if they purchasePaingone Plus Tens Pen .Apart from the...
PR Newswire
14/09/2023

Neoss® Group launches NeoTell™ a new device to measure implant stability.

NeoTell empowers dental professionals with an intuitive and user-friendly device that delivers objective results without invasive procedures. With this proven technology, clinicians can make informed treatment decisions swiftly and confidently. NeoTell empowers dental professionals with an intuitive and user-friendly device that delivers objective results without invasive procedures. With this proven technology, clinicians can make informed treatment decisions swiftly and confidently. One of...
PR Newswire
14/09/2023

Sectra's medical education portal to be used in Italian simulation center to…

Francesca Boccafoschi, professor at SIMNOVA says,"We are thrilled to collaborate with Sectra in utilizing their education portal in our medical simulation training across our campuses. Our mission is to improve patient care and reduce clinical risks through the use of simulation in the training, and Sectra's technology will allow us to study real-life clinical images. This greatly complements the simulation experience making our students even more prepared for the professional environments…
PR Newswire
14/09/2023

Suvoda Expands Its Presence in Romania with the Opening of an Office in Iași

This strategic move further enhances Suvoda's ability to meet increasing global demand following the company's successful launch of its clinical trial technology platform and powerful new eCOA solution earlier this year. Suvoda's Iași office, which officially opened in July, will house teams specializing in product development, software engineering, and professional services, with plans to expand into other areas as the company grows. This strategic move further enhances Suvoda's ability to...
PR Newswire
14/09/2023

Antimicrobial Resistance Market to Reach $9.5 Billion, Globally, by 2032 at 7.6%…

Request Sample of the Report on Antimicrobial Resistance Market Forecast 2032- Allied Market Research- https://www.alliedmarketresearch.com/request-sample/180698 Request Sample of the Report on Antimicrobial Resistance Market Forecast 2032- Allied Market Research-https://www.alliedmarketresearch.com/request-sample/180698 Antimicrobial resistance, often abbreviated as AMR, is the term used to describe the ability of microorganisms to resist the effects of various antimicrobial...
PR Newswire
14/09/2023

Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for…

Mucosal route induces both localized and systemic immunityIntravacc is currently developing 3 OMV-based intranasal vaccinesArticle published in peer-reviewed journal 'Current Opinions in Immunology'BILTHOVEN, Netherlands, Sept.14, 2023(GLOBE NEWSWIRE) -- Intravacc , a leading Contract Development and Manufacturing Organization (CDMO) specializing in translational research and the development of preventive and therapeutic vaccines, has announced the publication of a review on...
Nasdaq GlobeNewswire
14/09/2023

Kawasaki Medical School: Testing brain activity to decipher chronic indigestion

Functional dyspepsia and IBS are examples of disorders of gut–brain interaction (DGBI), which can have a long-term negative impact on patients' social and mental health, leading to decreased quality of life and reduced productivity at work. Each condition affects between 2% and 3% of the population of Japan. Functional dyspepsia and IBS are examples of disorders of gut–brain interaction (DGBI), which can have a long-term negative impact on patients' social and mental health, leading to...
PR Newswire
14/09/2023
Altri  Comunicati